David Merryman Archive — Page 1 of 1

November 15, 2018

Vanderbilt study suggests way to prevent rare lung disease

Research by Vanderbilt scientists suggests that it may be possible to prevent or even reverse pulmonary arterial hypertension, a rare, progressive disease characterized by narrowing of and high blood pressure in the small arteries of the lungs.

By Bill Snyder
David Merryman, associate professor of biomedical engineering, found that a drug developed for rheumatoid arthritis stops a common binding protein from calcifying heart valves. (Vanderbilt University)
June 12, 2017

Drug developed for arthritis could be first to stop heart valve calcification

The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis.

By Vanderbilt Health News
tiny petri dishes with wires in them
February 22, 2017

Organ-on-a-chip mimics heart’s biomechanical properties

Scientists at Vanderbilt University have created a three-dimensional organ-on-a-chip that can mimic the heart’s amazing biomechanical properties in order to study cardiac disease, develop heart drugs.

By Vanderbilt Health News
February 6, 2017

Twelve faculty members selected as 2017 Chancellor Faculty Fellows

The 2017 class of Chancellor Faculty Fellows comprises highly accomplished, recently tenured faculty from across the university.

By Vanderbilt Health News
February 23, 2016

Hypertension hiatus

New findings offer a potential strategy for preventing heritable pulmonary arterial hypertension.

By Bill Snyder
February 14, 2013

Cell connections key in valve disease

A protein that connects cells together participates in the calcification that occurs in heart valve disease.

By Leigh MacMillan